Evidence map›Paper›PMID 34370701›Full record

ArticleThe American journal of tropical medicine and hygiene2021

Severe COVID-19 in Uganda across Two Epidemic Phases: A Prospective Cohort Study.

Barnabas Bakamutumaho, Matthew J Cummings, Nicholas Owor, John Kayiwa, Joyce Namulondo, Timothy Byaruhanga, Moses Muwanga, Christopher Nsereko, Emmanuel Rwamutwe, Roselyn Mutonyi and 12 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Circulation of SARS-CoV-2 and Co-Infection withInfectious disease reports · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

Barnabas Bakamutumaho1Uganda Virus Research Institute, Entebbe, Uganda.
Matthew J Cummings2Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
Nicholas Owor1Uganda Virus Research Institute, Entebbe, Uganda.
John Kayiwa1Uganda Virus Research Institute, Entebbe, Uganda.
Joyce Namulondo1Uganda Virus Research Institute, Entebbe, Uganda.
Timothy Byaruhanga1Uganda Virus Research Institute, Entebbe, Uganda.
Moses Muwanga4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Christopher Nsereko4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Emmanuel Rwamutwe4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Roselyn Mutonyi4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Josephine Achan4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Lucy Wanyenze4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Alice Ndazarwe4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Ruth Nakanjako4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Richard Natuhwera4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Annet Nsangi4Entebbe Regional Referral Hospital, Entebbe, Uganda.
Henry Kyobe Bosa1Uganda Virus Research Institute, Entebbe, Uganda.
Felix Ocom6Ministry of Health, Kampala, Uganda.
Max R O'Donnell2Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
Bernard Kikaire1Uganda Virus Research Institute, Entebbe, Uganda.
Julius J Lutwama1Uganda Virus Research Institute, Entebbe, Uganda.
Collaboration for Clinical and Laboratory Characterization of COVID-19 in Uganda
Ministry of Agriculture, Animal Industry and Fisheries · UGUganda Virus Research Institute · UGColumbia University · USMakerere University · UGMinistry of Health · UG

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
TB and Other Pulmonary Complications of AIDS Research Training ProgramD43TW009607 · FIC · YALE UNIVERSITY · PI DAVIS, JOHN LUCIAN, KATAMBA, ACHILLES · 2013 to 2022
$3.2M
FIC NIH HHS D43 TW009607NCATS NIH HHS UL1 TR001873
6 · The paper itself

Abstract

Among a prospective cohort of children and adults admitted to a national COVID-19 treatment unit in Uganda from March to December 2020, we characterized the epidemiology of and risk factors for severe illness. Across two epidemic phases differentiated by varying levels of community transmission, the proportion of patients admitted with WHO-defined severe COVID-19 ranged from 5% (7/146; 95% CI: 2-10) to 33% (41/124; 95% CI: 25-42); 21% (26/124; 95% CI: 14-29%) of patients admitted during the peak phase received oxygen therapy. Severe COVID-19 was associated with older age, male sex, and longer duration of illness before admission. Coinfection with HIV was not associated with illness severity; malaria or tuberculosis coinfection was rare. No patients died during admission. Despite low mortality, hospital incidence of severe COVID-19 during the first epidemic peak in Uganda was substantial. Improvements in vaccine deployment and acute care capacity, including oxygen delivery, are urgently needed to prevent and manage severe COVID-19 in sub-Saharan Africa.

Indexed as

SARS-CoV-2AdultCOVID-19FemaleHumansMaleMiddle AgedProspective StudiesSeverity of Illness IndexUganda

Identifiers

PMID34370701
PMCPMC8592357
OpenAlexW3188970731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.